Marshall Wace’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.91M Sell
65,723
-3,694
-5% -$266K ﹤0.01% 1387
2026
Q1
$4.94M Sell
69,417
-1,706
-2% -$117K ﹤0.01% 1312
2025
Q4
$4.21M Sell
71,123
-157,078
-69% -$8.53M ﹤0.01% 1231
2025
Q3
$12.6M Buy
228,201
+156,301
+217% +$8.13M 0.01% 831
2025
Q2
$3.1M Sell
71,900
-102,559
-59% -$3.96M ﹤0.01% 1357
2025
Q1
$6.91M Sell
174,459
-32,546
-16% -$1.44M 0.01% 925
2024
Q4
$8.44M Buy
207,005
+11,407
+6% +$475K 0.01% 856
2024
Q3
$7.63M Sell
195,598
-23,548
-11% -$938K 0.01% 856
2024
Q2
$9.58M Sell
219,146
-147,825
-40% -$7.14M 0.01% 748
2024
Q1
$17.5M Buy
+366,971
New +$16.5M 0.03% 558
2023
Q3
Sell
-10,559
Closed -$614K 2520
2023
Q2
$614K Buy
+10,559
New +$633K ﹤0.01% 1909
2022
Q3
Sell
-32,538
Closed -$2.05M 3652
2022
Q2
$2.05M Buy
+32,538
New +$2.12M ﹤0.01% 1969
2020
Q4
Sell
-7,919
Closed -$391K 2082
2020
Q3
$391K Sell
7,919
-78,995
-91% -$4.46M ﹤0.01% 1302
2020
Q2
$4.57M Buy
86,914
+12,828
+17% +$609K 0.03% 496
2020
Q1
$2.61M Buy
74,086
+71,678
+2,977% +$4.19M 0.03% 543
2019
Q4
$210K Buy
2,408
+253
+12% +$22.1K ﹤0.01% 1336
2019
Q3
$183K Buy
+2,155
New +$192K ﹤0.01% 1298
2019
Q2
Sell
-265
Closed -$28K 1675
2019
Q1
$28K Sell
265
-87,730
-100% -$8.81M ﹤0.01% 1604
2018
Q4
$7.36M Buy
+87,995
New +$7.97M 0.08% 333
2017
Q1
Sell
-6,368
Closed -$349K 599
2016
Q4
$349K Buy
+6,368
New +$305K ﹤0.01% 872

Other funds holding NGVT

Marshall Wace's NGVT Position: Q2 2026 in Review

Marshall Wace reduced its Ingevity (NGVT) stake by 5.3% in Q2 2026, selling an estimated $266K and leaving 65,723 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Marshall Wace first reported a position in NGVT in Q4 2016 and has held it in 20 quarters since. The position peaked at $17.5M in Q1 2024. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Marshall Wace held 65,723 shares of Ingevity worth $4.91M as of Q2 2026.
  • Marshall Wace sold 3,694 Ingevity shares in Q2 2026, an estimated $266K.
  • Ingevity made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1387 holding.
  • Marshall Wace first reported a position in Ingevity in Q4 2016 and has held it in 20 quarters since.
  • Marshall Wace's Ingevity position peaked at $17.5M in Q1 2024.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.